Search filters

List of works by Yvonne Freund-Levi

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

scientific article published on 18 December 2019

Agitation and impulsivity in mid and late life as possible risk markers for incident dementia

scientific article published on 06 September 2020

Agitation in dementia: relation to core cerebrospinal fluid biomarker levels

scientific article

Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data.

scientific article published on 25 June 2018

Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study

scientific article

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

scientific article published on 29 November 2017

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

scientific article published on 13 September 2019

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

scientific article published on 08 March 2019

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease

scientific article published on 28 March 2022

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

scientific article published on 29 December 2017

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.

scientific article

Detection of amyloid in Alzheimer's disease with positron emission tomography using [11C]AZD2184.

scientific article published on 05 June 2009

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

scientific article published on 20 August 2020

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

scientific article published on 05 September 2019

Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?

scientific article published on 14 November 2017

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

scientific article published on 01 June 2019

Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study

scientific article

Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid

scientific article published on 28 February 2017

Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study.

scientific article

Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study

scientific article

Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study

scientific article

Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study

scientific article published in January 2014

Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study

scientific article published in January 2013

Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study

scientific article published on 25 June 2014

Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial

scientific article published on 10 September 2013

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study

scientific article published on 01 January 2019

Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid

scientific article published on March 2012

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

scientific article published on January 2017

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

scientific article published on 06 April 2019

Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients

scientific article published on 17 January 2013

Neuropsychiatric symptoms in dementia-a role for neuroinflammation?

scientific article

Nutritional Considerations for Healthy Aging and Reduction in Age-Related Chronic Disease

scientific article published on 17 January 2017

Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease study

scientific article published on 20 November 2008

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial

scientific article published in October 2006

Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers

scientific article published on January 2013

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

scientific article published on February 2008

Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited

scientific article published in October 2007

Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study

scientific article published on 04 September 2015

Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers

scientific article published on 16 February 2017

Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage

scientific article published on 17 February 2015

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

scientific article published on 10 June 2009

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

scientific article published on May 2015

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

scientific article published on 27 March 2018

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

scientific article published on 08 May 2019

Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD study

scientific article

Response to Bogaiksy's letter to the editor

scientific article published on 2 June 2014

The frequency and influence of dementia risk factors in prodromal Alzheimer's disease

scientific article published on 08 April 2017

Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study

scientific article

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

scientific article published on 01 January 2020

[Administration of symptom-relieving drugs in Alzheimer disease is beneficial]

scientific article published on 01 February 2006

Paulina is supported by:

About Paulina

Help